Top

Journal of Endocrinological Investigation

Published in:

01-12-2017 | Consensus Statement

The use of nutraceuticals in male sexual and reproductive disturbances: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS)

Authors: A. E. Calogero, A. Aversa, S. La Vignera, G. Corona, A. Ferlin

Published in: Journal of Endocrinological Investigation | Issue 12/2017

Excerpt

The term “nutraceutical” is a neologism derived from “nutrition” and “pharmaceutical”, coined in 1989 by Stephen De Felice to describe “a food or part of it that determines the overall health benefits, including prevention and/or treatment of diseases” [1]. Nutraceuticals include many products today. Among these, the most studied for possible positive effects are plant derivatives (herbal) [2]. Pharmaceutical herbal preparations consist of roots, seeds, pollen, bark, or fruit, alone or in combination [2, 3]. Many botanical extracts and herbs, such as ginseng, garlic, onion, etc., have nutraceutical properties [1]. Nutraceuticals may be taken either by introducing functional foods in the diet, in the form of simple or enriched food of a specific active principle, or as food supplements in liquid, tablet, or capsule formulation. …

Brower V (2005) A nutraceutical a day may keep the doctor away. EMBO Rep 6:708–711CrossRefPubMedPubMedCentral

Calogero AE, Condorelli RA, Russo GI, La Vignera S (2017) Conservative nonhormonal options for the treatment of male infertility: antibiotics, anti-inflammatory drugs, and antioxidants. Biomed Res Int 2017:4650182CrossRefPubMedPubMedCentral

Malde S, Nambiar AK, Umbach R, Lam TB, Bach T, Bachmann A, Drake MJ, Gacci M, Gratzke C, Madersbacher S, Mamoulakis C, Tikkinen KA, Gravas S (2017) Systematic review of the performance of noninvasive tests in diagnosing bladder outlet obstruction in men with lower urinary tract symptoms. European Association of Urology Non-Neurogenic Male LUTS guidelines panel. Eur Urol 71:391–402CrossRefPubMed

Krausz C (2011) Male infertility: pathogenesis and clinical diagnosis. Best Pract Res Clin Endocrinol Metab 25:271–285CrossRefPubMed

Gabrielsen JS, Tanrikut C (2016) Chronic exposures and male fertility: the impacts of environment, diet, and drug use on spermatogenesis. Andrology 4:648–661CrossRefPubMed

Ferlin A, Foresta C (2014) New genetic markers for male infertility. Curr Opin Obstet Gynecol 26:193–198CrossRefPubMed

Cui T, Kovell RC, Brooks DC, Terlecki RP (2015) A urologist’s guide to ingredients found in top-selling nutraceuticals for men’s sexual health. J Sex Med 12:2105–2117CrossRefPubMed

European Monitoring Centre for Drugs and Drug Addictions (2012) Annual report on the state of the drugs problem in Europe. http://www.emcdda.europa.eu/publications/annual-report/2012. Accessed 03 Mar 2017

Swiglo BA, Murad MH, Schünemann HJ, Kunz R, Vigersky RA, Guyatt GH, Montori VM (2008) A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metab 93:666–673CrossRefPubMed

10.

Balercia G, Gandini L, Lenzi A, Lombardo F (2017) Antioxydants in andrology. Springer, Cham, SwitzerlandCrossRef

11.

Tremellen K (2008) Oxidative stress and male infertility—a clinical perspective. Hum Reprod Update 14:243–258CrossRefPubMed

12.

Bykova M, Athayde K, Sharma R, Jha R, Sabanegh E, Agarwal A (2007) Defining the reference value of seminal reactive oxygen species in a population of infertile men and normal healthy volunteers. Fertil Steril 88:305CrossRef

13.

Agarwal A, Allamaneni SS, Nallella KP, George AT, Mascha E (2005) Correlation of reactive oxygen species levels with the fertilization rate after in vitro fertilization: a qualified meta-analysis. Fertil Steril 84:228–231CrossRefPubMed

14.

Tamburrino L, Marchiani S, Montoya M, Elia Marino F, Natali I, Cambi M, Forti G, Baldi E, Muratori M (2012) Mechanisms and clinical correlates of sperm DNA damage. Asian J Androl 14:24–31CrossRefPubMed

15.

Robinson L, Gallos ID, Conner SJ, Rajkhowa M, Miller D, Lewis S, Kirkman-Brown J, Coomarasamy A (2012) The effect of sperm DNA fragmentation on miscarriage rates: a systematic review and meta-analysis. Hum Reprod 27:2908–2917CrossRefPubMed

16.

Osman A, Alsomait H, Seshadri S, El-Toukhy T, Khalaf Y (2015) The effect of sperm DNA fragmentation on live birth rate after IVF or ICSI: a systematic review and meta-analysis. Reprod Biomed Online 30:120–127CrossRefPubMed

17.

Showell MG, Mackenzie-Proctor R, Brown J, Yazdani A, Stankiewicz MT, Hart RJ (2014) Antioxidants for male subfertility. Cochrane Database Syst Rev 12:CD00741

18.

Showell MG, Brown J, Yazdani A, Stankiewicz MT, Hart RJ (2011) Antioxidants for male subfertility. Cochrane Database Syst Rev 1:CD007411

19.

Filippi S, Luconi M, Granchi S, Natali A, Tozzi P, Forti G, Ledda F, Maggi M (2002) Endothelium-dependency of yohimbine-induced corpus cavernosum relaxation. Int J Impot Res 14:295–307CrossRefPubMed

20.

Ernst E, Pittler MH (1998) Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol 159:433–436CrossRefPubMed

21.

Qureshi A, Naughton DP, Petroczi A (2014) A systematic review on the herbal extract Tribulus terrestris and the roots of its putative aphrodisiac and performance enhancing effect. J Diet Suppl 11:64–79CrossRefPubMed

22.

Kamenov Z, Fileva S, Kalinov K, Jannini EA (2017) Evaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction? A prospective, randomized, double-blind, placebo-controlled clinical trial. Maturitas 99:20–26CrossRefPubMed

23.

Corona G, Rastrelli G, Giagulli VA, Sila A, Sforza A, Forti G, Mannucci E, Maggi M (2013) Dehydroepiandrosterone supplementation in elderly men: a meta-analysis study of placebo-controlled trials. J Clin Endocrinol Metab 98:3615–3626CrossRefPubMed

24.

Cui T, Kovell RC, Brooks DC, Terlecki RP (2015) A urologist’s guide to ingredients found in top-selling nutraceuticals for men’s sexual health. J Sex Med 12:2105–2117CrossRefPubMed

25.

Mollace V, Malara N, Gratteri S, Palma E, Zappia L, Costa N, Rosano G, Paone S (2016) Bergamot polyphenolic fraction counteracts erectile dysfunction occurring in patients suffering from type 2 diabetes. Pharmanutrition 4S:S41–S46CrossRef

26.

Rastrelli G, Corona G, Tarocchi M, Mannucci E, Maggi M (2016) How to define hypogonadysm? Results from a population of men consulting for sexual dysfunction. J Endocrinol Invest 39:473–484CrossRefPubMed

27.

Isidori AM, Balercia G, Calogero AE, Corona Ferlin G, Francavilla A, Santi D, Maggi M (2015) Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology. J Endocrinol Invest 38:103–112CrossRefPubMed

28.

Jang DJ, Lee MS, Shin BC, Lee YC, Ernst E (2008) Red ginseng for treating erectile dysfunction: a systematic review. Br J Clin Pharmacol 66:444–450CrossRefPubMedPubMedCentral

29.

Lombardo F, Sgrò P, Gandini L, Dondero F, Jannini EA, Lenzi A (2004) Might erectile dysfunction be due to the thermolabile variant of methylenetetrahydrofolate reductase? J Endocrinol Invest 27(9):883–885CrossRefPubMed

30.

Lombardo F, Tsamatropoulos P, Piroli E, Culasso F, Jannini EA, Dondero F, Lenzi A, Gandini L (2010) Treatment of erectile dysfunction due to C677T mutation of the MTHFR gene with vitamin B6 and folic acid in patients non responders to PDE5i. J Sex Med 7(1 Pt 1):216–223CrossRefPubMed

31.

Rastelli G, Giovannini L, Calogero AE, Gianfrilli D, Serra E, Pizzocaro A, Giagulli VA, Motta G, Vancieri G, Sperandio A, Andò S, Selice R, Luca G, Cocchiara F, Canale D, Maggi M (2016) Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registry. J Endocrinol Invest 39:695–708CrossRef

32.

Wilt T, Ishani A, Mac Donald R, Rutks I, Stark G (2002) Pygeumafricanum for benign prostatic hyperplasia. Cochrane Database Syst Rev 1:CD001044

33.

Wilt TJ, Macdonald R, Ishani A, Rutks I, Stark G (2011) WITHDRAWN: cernilton for benign prostatic hyperplasia. Cochrane Database Syst Rev 5:CD001042

34.

Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ (2012) Serenoarepens for benign prostatic hyperplasia. Cochrane Database Syst Rev 12:CD001423PubMed

35.

Morgia G, Russo GI, Voce S, Palmieri F, Gentile M, Giannantoni A, Blefari F, Carini M, Minervini A, Ginepri A, Salvia G, Vespasiani G, Santelli G, Cimino S, Allegro R, Collura Z, Fragalà E, Arnone S, Pareo RM (2014) Serenoarepens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial). Prostate 74:1471–1480CrossRefPubMed

36.

Anothaisintawee T, Attia J, Nickel JC, Thammakraisorn S, Numthavaj P, McEvoy M, Thakkinstian A (2011) Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA 305:78–86CrossRefPubMed

37.

Festuccia C, Mancini A, Gravina GL, Scarsella L, Llorens S, Alonso GL, Tatone C, Di Cesare E, Jannini EA, Lenzi A, D’Alessandro AM, Carmona M (2014) Antitumoreffects of saffron-derived carotenoids in prostate cancercellmodels. Biomed Res Int 2014:135048CrossRefPubMedPubMedCentral

38.

Mishra M, Acharya UR (2004) Protective action of vitamins on the spermatogenesis in lead-treated Swiss mice. J Trace Elem Med Biol 18:173–178CrossRefPubMed

39.

Song GJ, Norkus EP, Lewis V (2006) Relationship between seminal ascorbic acid and sperm DNA integrity in infertile men. Int J Androl 29:569–575CrossRefPubMed

40.

Moncada LM, Vicari E, Cimino C, Calogero AE, Mongioì A, D’Agata R (1992) Effect of acetylcarnitine treatment in oligoasthenospermic patients. Acta Eur Fertil 23:221–224PubMed

41.

Costa M, Canale D, Filicori M, D’lddio S, Lenzi A (1994) l-Carnitine in idiopathic asthenozoospermia: a multicenterstudy. Andrologia 26:155–159CrossRefPubMed

42.

Vitali G, Parente R, Melotti C (1995) Carnitine supplementation in human idiopathic asthenospermia: clinical results. Drugs Exp Clin Res 21:157–159PubMed

43.

Banihani S, Agarwal A, Sharma R, Bayachou M (2014) Cryoprotective effect of l-carnitine on motility, vitality and DNA oxidation of human spermatozoa. Andrologia 46:637–641CrossRefPubMed

44.

Vicari E, La Vignera S, Calogero AE (2002) Antioxidant treatment with carnitines is effective in infertile patients with prostatovesiculoepididymitis and elevated seminal leukocyte concentrations after treatment with nonsteroidal anti-inflammatory compounds. Fertil Steril 78:1203–1208CrossRefPubMed

45.

Gupta NP, Kumar R (2002) Lycopene therapy in idiopathic male infertility—a preliminary report. Int Urol Nephrol 34:369–372CrossRefPubMed

46.

Mongioì LM, Calogero AE, Vicari E, Condorelli RA, Russo GI, Privitera S, Morgia G, La Vignera S (2016) The role of carnitine in male infertility. Andrology 4:800–807CrossRefPubMed

47.

Balercia G, Mancini A, Paggi F, Tiano L, Pontecorvi A, Boscaro M, Lenzi A, Littarru GP (2009) Coenzyme Q10 and male infertility. J Endocrinol Invest 32:626–632CrossRefPubMed

48.

Balercia G, Buldreghini E, Vignini A, Tiano L, Paggi F, Amoroso S, Ricciardo-Lamonica G, Boscaro M, Lenzi A, Littarru G (2009) Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. Fertil Steril 91:1785–1792CrossRefPubMed

49.

Safarinejad MR, Safarinejad S (2009) Efficacy of selenium and/or N-acetyl-cysteine for improving semen parameters in infertile men: a double-blind, placebo controlled, randomized study. J Urol 181:741–751CrossRefPubMed

50.

Nadjarzadeh A, Sadeghi MR, Amirjannati N, Vafa MR, Motevalian SA, Gohari MR, Akhondi MA, Yavari P, Shidfar F (2011) Coenzyme Q10 improves seminal oxidative defense but does not affect on semen parameters in idiopathic oligoasthenoteratozoospermia: a randomized double-blind, placebo controlled trial. J Endocrinol Invest 34:224–228

51.

Condorelli RA, La Vignera S, Di Bari F, Unfer V, Calogero AE (2011) Effects of myoinositol on sperm mitochondrial function in-vitro. Eur Rev Med Pharmacol Sci 15:129–134PubMed

52.

Calogero AE, Gullo G, La Vignera S, Condorelli RA, Vaiarelli A (2015) Myoinositol improves sperm parameters and serum reproductive hormones in patients with idiopathic infertility: a prospective double-blind randomized placebo-controlled study. Andrology 3:491–495CrossRefPubMed

53.

Condorelli RA, La Vignera S, Bellanca S, Vicari E, Calogero AE (2012) Myoinositol: does it improve sperm mitochondrial function and sperm motility? Urology 79:1290–1295CrossRefPubMed

54.

Irvine DS (1996) Glutathione as a treatment for male infertility. Rev Reprod 1:6–12CrossRefPubMed

55.

Lenzi A, Picardo M, Gandini L, Lombardo F, Terminali O, Passi F, Dondero F (1994) Glutathione treatment of dyspermia: effect on the lipoperoxidation process. Hum Reprod 9:2044–2050CrossRefPubMed

56.

Walczak-Jedrzejowska R, Wolski JK, Slowikowska-Hilczer J (2013) The role of oxidative stress and antioxidants in male fertility. Cent Eur J Urol 66:60–67CrossRef

57.

Ciftci H, Verit A, Savas M, Yeni E, Erel O (2009) Effects of N-acetylcysteine on semen parameters and oxidative/antioxidant status. Urology 74:73–76CrossRefPubMed

58.

Thérond P, Auger J, Legrand A, Jouannet P (1996) α-Tocopherol in human spermatozoa and seminal plasma: relationships with motility, antioxidant enzymes and leukocytes. Mol Hum Reprod 2:739–744CrossRefPubMed

59.

Cho KS, Park CW, Kim CK, Jeon HY, Kim WG, Lee SJ, Kim YM, Lee JY, Choi YD (2013) Effects of Korean ginseng berry extract (GB0710) on penile erection: evidence from in vitro and in vivo studies. Asian J Androl 15:503–507CrossRefPubMedPubMedCentral

60.

Prasad AS, Mantzoros CS, Beck FW, Hess JW, Brewer GJ (1996) Zinc status and serum testosterone levels of healthy adults. Nutrition 12:344–348CrossRefPubMed

61.

Mouw DR, Latessa RA, Hickner J (2005) Clinical inquiries. What are the causes of hypomagnesemia? J Fam Pract 54:174–176PubMed

62.

Mirone M, Giannetta E, Isidori AM (2013) Selenium and reproductive function. A systematic review. J Endocrinol Invest 36:28–36PubMed

63.

Shindel AW, Xin ZC, Lin G, Fandel TM, Huang YC, Banie L, Breyer BN, Garcia MM, Lin CS, Lue TF (2010) Erectogenic and neurotrophic effects of icariin, a purified extract of horny goat weed (Epimedium spp.) in vitro and in vivo. J Sex Med 7:1518–1528CrossRefPubMedPubMedCentral

64.

Stanger O, Fowler B, Piertzik K, Huemer M, Haschke-Becher E, Semmler A, Lorenzl S, Linnebank M (2009) Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations. Expert Rev Neurother 9:1393–1412CrossRefPubMed

65.

Ng CF, Lee CP, Ho AL, Lee VW (2011) Effect of niacin on erectile function in men suffering erectile dysfunction and dyslipidemia. J Sex Med 8:2883–2893CrossRefPubMed

66.

Tjandra BS, Janknegt RA (1997) Neurogenic impotence and lower urinary tract symptoms due to vitamin B1 deficiency in chronic alcoholism. J Urol 157:954–955CrossRefPubMed

67.

Varjas T, Nowrasteh G, Budán F, Horváth G, Cseh J, Gyöngyi Z, Makai S, Ember I (2011) The effect of fenugreek on the gene expression of arachidonic acid metabolizing enzymes. Phytother Res 25:221–227PubMed

68.

Stanislavov R, Nikolova V (2003) Treatment of erectile dysfunction with pycnogenol and l-arginine. J Sex Marital Ther 29:207–213CrossRefPubMed

69.

Cormio L, De Siati M, Lorusso F, Selvaggio O, Mirabella L, Sanguedolce F, Carrieri G (2011) Oral l-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. Urology 77:119–122CrossRefPubMed

70.

Corazza O, Martinotti G, Santacroce R, Chillemi E, Di Giannantonio M, Schifano F, Cellek S (2014) Sexual enhancement products for sale online: raising awareness of the psychoactive effects of yohimbine, maca, horny goat weed, and Ginkgo biloba. Biomed Res Int 2014:841798CrossRefPubMedPubMedCentral

71.

Schwarz S, Obermuller-Jevic UC, Hellmis E, Koch W, Jacobi G, Biesalski HK (2008) Lycopene inhibits disease progression in patients with benign prostate hyperplasia. J Nutr 138:49–53PubMed

72.

McConnell JD, Bruskewitz R, Walsh P, Andriole G, Lieber M, Holtgrewe HL, Albertsen P, Roehrborn CG, Nickel JC, Wang DZ, Taylor AM, Waldstreicher J (1998) The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride long-term efficacy and safety study group. N Engl J Med 338:557–563CrossRefPubMed

73.

Siddiqui IA, Adhami VM, Saleem M, Mukhtar H (2006) Beneficial effects of tea and its polyphenols against prostate cancer. Mol Nutr Food Res 50:130–143CrossRefPubMed

74.

Vela Navarrete R, Garcia Cardoso JV, Barat A, Manzarbeitia F, Lopez Farre A (2003) BPH and inflammation: pharmacological effects of permixon on histological and molecular inflammatory markers. Results of a double blind pilot clinical assay. Eur Urol 44:549–555CrossRefPubMed

Title: The use of nutraceuticals in male sexual and reproductive disturbances: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS)
Authors: A. E. Calogero
A. Aversa
S. La Vignera
G. Corona
A. Ferlin
Publication date: 01-12-2017
Publisher: Springer International Publishing
Published in: Journal of Endocrinological Investigation / Issue 12/2017
Electronic ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-017-0699-6

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2017

The relationship between hyperthyrotropinemia and metabolic and cardiovascular risk factors in a large group of overweight and obese children and adolescents

The relationship between circulating adiponectin, leptin and vaspin with bone mineral density (BMD), arterial calcification and stiffness: a cross-sectional study in post-menopausal women

Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome

Vitamin D receptor and progesterone receptor protein and gene expression in papillary thyroid carcinomas: associations with histological features

Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors

Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials